This may be addressed in future studies using for instance a B16F10 melanoma model deficient for P2X7 expression, to better delineate the potential beneficial effect of P2X7 stimulation on immune cells, from its detrimental effect on the tumor cells themselves. The gene discussed is P2RX7; the disease is melanoma.